California State Teachers Retirement System (CalSTRS)’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,767	Closed	-$502K	–	3122
2020 Q4	$502K	Buy	21,767 +431	+2%	+$5.46K	﹤0.01%	2424
2020 Q3	$217K	Buy	21,336 +8	+0%	+$107	﹤0.01%	2683
2020 Q2	$318K	Hold	21,328	–	–	﹤0.01%	2471
2020 Q1	$260K	Buy	21,328 +9,769	+85%	+$155K	﹤0.01%	2420
2019 Q4	$183K	Hold	11,559	–	–	﹤0.01%	2817
2019 Q3	$142K	Buy	+11,559	New	+$131K	﹤0.01%	2889

California State Teachers Retirement System (CalSTRS)'s PRVL Position: Q1 2021 in Review

California State Teachers Retirement System (CalSTRS) sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 21,767 shares — an estimated $502K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in PRVL in Q3 2019 and held it in 6 quarters. The position peaked at $502K in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

California State Teachers Retirement System (CalSTRS) reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
California State Teachers Retirement System (CalSTRS) sold 21,767 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $502K.
California State Teachers Retirement System (CalSTRS) first reported a position in Prevail Therapeutics Inc. Common Stock in Q3 2019 and held it in 6 quarters.
California State Teachers Retirement System (CalSTRS)'s Prevail Therapeutics Inc. Common Stock position peaked at $502K in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2021, filed 18 May 2021.